Skip to content

Phoenix Life Sciences International Limited.: 10-Q filed 2013-04-23

What Phoenix Life Sciences International Limited. reported in its quarterly report filed 2013-04-23 (fiscal Q1 2012): 23 published measures, 63 facts as tagged in accession 0001078782-13-000812.

This filing

Form
10-Q (quarterly report)
Filed
2013-04-23
Fiscal period
fiscal Q1 2012
Accession
0001078782-13-000812 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Phoenix Life Sciences International Limited. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-05-3146,143USD
At 2012-02-2923,949USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-05-31-495,609USD
At 2012-02-29-170,247USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-05-3128,059USD
At 2012-02-29191USD
At 2011-05-3160,598USD
At 2011-02-281,141USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-325,362USD92
2009-04-21 to 2012-05-31-606,966USD1137
2011-03-01 to 2011-05-31-21,619USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-37,132USD92
2009-04-21 to 2012-05-31-181,771USD1137
2011-03-01 to 2011-05-31-8,373USD92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-03-01 to 2012-05-313,517USD92
2009-04-21 to 2012-05-317,834USD1137
2011-03-01 to 2011-05-310USD92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-03-01 to 2012-05-3165,000USD92
2009-04-21 to 2012-05-31259,330USD1137
2011-03-01 to 2011-05-31117,330USD92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-03-01 to 2012-05-310USD92
2009-04-21 to 2012-05-31-49,500USD1137
2011-03-01 to 2011-05-31-49,500USD92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-52,244USD92
2009-04-21 to 2012-05-31-320,991USD1137
2011-03-01 to 2011-05-31-21,619USD92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-05-3129,000USD
At 2012-02-292,355USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-4,464USD92
2009-04-21 to 2012-05-31-17,321USD1137
2011-03-01 to 2011-05-310USD92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-05-31541,523USD
At 2012-02-29192,937USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-05-31941USD
At 2012-02-292,164USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-03-01 to 2012-05-3155,761USD92
2009-04-21 to 2012-05-31328,825USD1137
2011-03-01 to 2011-05-3121,619USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-05-317,800,000shares
At 2012-02-297,800,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-05-31103,557USD
At 2012-02-29103,557USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-03-01 to 2012-05-31-325,362USD92
2009-04-21 to 2012-05-31-606,966USD1137
2011-03-01 to 2011-05-31-21,619USD92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-03-01 to 2012-05-3136,655USD92
2009-04-21 to 2012-05-31170,953USD1137
2011-03-01 to 2011-05-3111,255USD92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-03-01 to 2012-05-31159USD92
2009-04-21 to 2012-05-31879USD1137
2011-03-01 to 2011-05-310USD92

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2012-03-01 to 2012-05-310USD92
2009-04-21 to 2012-05-310USD1137
2011-03-01 to 2011-05-310USD92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-03-01 to 2012-05-310USD92
2009-04-21 to 2012-05-3148,000USD1137
2011-03-01 to 2011-05-310USD92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-05-311,223USD92
2009-04-21 to 2012-05-31-941USD1137
2011-03-01 to 2011-05-310USD92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2012-05-3110,882USD92
2009-04-21 to 2012-05-3145,319USD1137
2011-03-01 to 2011-05-3115,246USD92

Inspect the source

Entity
Phoenix Life Sciences International Limited. / CIK 0001493212
Captured
SEC response SHA-256
e9e4eff3c476f5eb033bab91a133e7dfeaf63cfa51c8097afeedbc2cb284bfb3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001493212.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))